Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?
AbstractInflammatory diseases affect a large portion of the worldwide population, and chronic inflammation is a major risk factor for several dangerous pathologies. To limit the side effects of both synthetic and biological anti-inflammatory drugs, the use of herbal medicines, nutraceuticals and food supplements has increased tremendously as alternative and/or complementary medicine to treat several pathologies, including inflammation. During the last decades, the biological properties of Citrus bergamia (bergamot) derivatives have obtained important scientific achievements, and it has been suggested their use in a context of a multitarget pharmacological strategy. Here, we present an overview of the anti-inflammatory properties of bergamot extracts that could represent the scientific basis for develop novel and alternative strategies to improve health status and attenuate inflammatory conditions. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ferlazzo, N.; Cirmi, S.; Calapai, G.; Ventura-Spagnolo, E.; Gangemi, S.; Navarra, M. Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand? Molecules 2016, 21, 1273.
Ferlazzo N, Cirmi S, Calapai G, Ventura-Spagnolo E, Gangemi S, Navarra M. Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand? Molecules. 2016; 21(10):1273.Chicago/Turabian Style
Ferlazzo, Nadia; Cirmi, Santa; Calapai, Gioacchino; Ventura-Spagnolo, Elvira; Gangemi, Sebastiano; Navarra, Michele. 2016. "Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?" Molecules 21, no. 10: 1273.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.